Variation in Cardiovascular Risk Assessment Status in Patients Receiving Oral Anti-Cancer Therapies: A Focus on Equity throughout VISN (Veteran Integrated Service Network) 12September 11, 2024OncologyCancerCardiology
Implementing a Prospective Surveillance Physical Therapy Program for Those Affected by CancerSeptember 11, 2024Prostate CancerOncologyCancer
Developing a Cancer Rehabilitation Program—Improving Access to Ancillary Services to Mitigate the Impact of Cancer and its Treatments for Veterans Diagnosed With CancerSeptember 11, 2024OncologyCancer
Mortality Risk From Early-Onset CRC Higher in Rural, Poor AreasSeptember 11, 2024OncologyDiversity in MedicineColon and Rectal
Whole Health Oncology—Just Do It: Making Whole Person Cancer Care Routine and Regular at the Dayton VA Medical Center (DVAMC)September 11, 2024Prostate CancerOncologyCancerBreast Cancer
Neuroendocrine Tumor of Ampulla of Vater: A Rare Case Report and Review of LiteratureSeptember 11, 2024OncologyNeurology
Five Key Measures to Ensure a Quality ColonoscopySeptember 10, 2024Colorectal CancerOncologyColon and Rectal
“It Takes a Village”: Benefits and Challenges of Navigating Cancer Care with the Pacific Community and the Veterans Health AdministrationSeptember 10, 2024OncologyCancer
Influence of Patient Demographics and Facility Type on Overall Survival in Sezary SyndromeSeptember 10, 2024Oncology
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple MyelomaSeptember 10, 2024OncologyMultiple MyelomaHematologic Malignancies
